Earnings release · DGX
Quest Diagnostics Reports Third Quarter 2026 Financial Results
Quest Diagnostics Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$3.10 billion
+10% vs a year ago
EPS
$2.78
+28.7% vs a year ago
Guidance
raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue climbed 10% year on year to $3.10 billion, and EPS rose 28.7% to $2.78. Sales and earnings both ahead of a year ago is generally the cleaner kind of result. The company lifted its guidance, which is usually read as management's view of coming periods improving.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$3.10 billion +10% vs a year ago
…Third quarter revenues of $3.10 billion, up 10.0% from 2025, on strong organic revenue growth…
EPS
$2.78 +28.7% vs a year ago
…Third quarter reported diluted earnings per share ("EPS") of $2.78, up 28.7% from 2025; and adjusted diluted EPS of $3.00, up 15.4% from 2025…
Guidance
Guidance raised
…Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026…
Trend: last 1 reports
All releases →Revenue growth (YoY)
EPS growth (YoY)
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.